The Latest in AML

Hematology News

COVID-19: ASTCT provides interim guidelines for transplantation

March 16, 2020

Hematology News

Second transplant a good salvage option for children with ALL, AML, or MDS

March 16, 2020

Hematology News

Accelerated fetal growth in boys associated with development of AML

March 12, 2020

Hematology News

Initial FLAG-Ida outperforms 7+3 for high-risk AML

February 24, 2020

Oncology Practice

Survival for older AML patients better with HSCT from unrelated donors

February 8, 2020

Hematology News

9/11 responders show increased risk of leukemia, other cancers

January 14, 2020

Hematology News

Genomic profiling of AML and MDS yields prognostic clues

January 9, 2020

Hematology News

Oral azacitidine: First maintenance therapy for AML

December 13, 2019

Hematology News

Kidney function in African American AML patients not linked to reduced survival compared with whites

December 7, 2019

Hematology News

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019

Hematology News

Caspofungin bests fluconazole for antifungal prophylaxis in young AML patients

November 5, 2019

Hematology News

Hematopoietic cell transplant offers realistic cure in secondary AML

October 23, 2019

Hematology News

Adverse cytogenetics trump molecular risk in NPM1-mutated AML

October 15, 2019

Hematology News

Genetic analysis highlights value of germline variants in MDS, AML

September 18, 2019

Hematology News

Nonmyeloablative conditioning carries lowers infection risk in patients with AML

September 10, 2019